stimol powder for injection
citrulline maleate
stimol powder for oral solution.
citrulline maleate
floratil 250 mg powder for oral suspension
zuellig pharma corporation; distributor: zuellig pharma corporation - saccharomyces boulardii - powder for oral suspension - 250 mg
floratil 250 mg capsule
zuellig pharma corporation; distributor: zuellig pharma corporation - saccharomyces boulardii - capsule - 250 mg
nefalgic® 20 mg/2 ml injection
pharma solution drug store llc france - 20 ampoules (x 2 ml) - injection - 20 mg/2 ml - central nervous system-analgesics
otipax® combination drops
pharmazone medical equipments france - 1 vial + 1 dropper - drops - combination - ear nose , oropharynx-ear
floratil® 200mg 200 mg/capsule
pharmazone medical equipments france - 10’s blister - capsule - 200 mg/capsule - n/a-n/a
floratil® 100mg 100 mg /sachet suspension
pharmazone medical equipments france - 20 sachets - suspension - 100 mg /sachet - n/a-n/a
betmiga
astellas pharma europe b.v. - mirabegron - urinary bladder, overactive - urologicals - symptomatic treatment of urgency.increased micturition frequency and / or urgency incontinence as may occur in adult patients with overactive-bladder syndrome.
mycamine
astellas pharma europe b.v. - micafungin - candidiasis - antimycotics for systemic use - mycamine is indicated for:adults, adolescents ≥ 16 years of age and elderlytreatment of invasive candidiasis;treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate;prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem-cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count < 500 cells/µl) for 10 or more days.children (including neonates) and adolescents < 16 years of agetreatment of invasive candidiasis.prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem-cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count < 500 cells/µl) for 10 or more days.the decision to use mycamine should take into account a potential risk for the development of liver tumours. mycamine should therefore only be used if other antifungals are not appropriate.